QurAlis
Praveen Kumar Pogula is an accomplished professional in the field of drug design and therapeutics, currently serving as Director of Drug Sciences at QurAlis since November 2024. Previously, Praveen held the position of Associate Director at Korro Bio, Inc. from November 2021 to October 2024, focusing on RNA editing therapeutic platforms. Praveen's expertise includes mRNA medicine at Luye Pharma USA Ltd. and various roles in RNA and drug delivery systems at 1Globe Health Institute and South Dakota State University. Praveen completed a PhD in Chemistry at IICT, Hyderabad and holds a Master's degree in Organic Chemistry from Kakatiya University.
This person is not in any teams
QurAlis
1 followers
QurAlis is developing precision therapeutics for ALS, a terminal disease that causes muscle paralysis through degeneration of the motor system. They are digging deep into the root causes of the multiple sub-forms of this destructive disease and focus their programs on tackling specific disease-causing mechanisms.